Suppr超能文献

过氧化物酶体增殖物激活受体γ- Toll样受体4-肿瘤坏死因子-α靶向通路对高血糖诱导的心肌炎症和氧化应激的影响

[Effects of peroxisome proliferator-activated receptor γ-toll-like receptor 4-tumor necrosis factor-α targeted pathway on hyperglycemia induced myocardium inflammation and oxidative stress].

作者信息

Liu Changle, Liu Ruimeng, Wu Xiaohan, Tan Peize, Fu Huaying, Wang Xinghua, Liu Tong, Li Guangping

机构信息

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Department of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China (Liu CL, Liu RM, Wu XH, Fu HY, Wang XH, Liu T, Li GP); Tianjin First-aid Center, Tianjin 300011, China (Tan PZ). Corresponding author: Liu Changle, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 May;30(5):416-421. doi: 10.3760/cma.j.issn.2095-4352.2018.05.005.

Abstract

OBJECTIVE

To investigate the potential effects and mechanism on peroxisome proliferator-activated receptor γ-toll-like receptor 4-tumor necrosis factor-α (PPARγ-TLR4-TNF-α) targeted pathway on hyperglycemia induced myocardium inflammation and oxidative stress.

METHODS

Thirty-two Japanese healthy adult rabbits were randomly divided into four groups with 8 rabbits in each group: normal control group (NC group), diabetes mellitus group (DM group), diabetes mellitus + pioglitazone 4 mg×kg×d and 8 mg×kg×d groups (DM+PGZ 4 mg and 8 mg groups). DM model was reproduced by alloxan of 150 mg/kg through auricular vein injection. On the same day of successful DM model reproduction, the diabetic rabbits were fed with corresponding dose of pioglitazone in DM+PGZ 4 mg and 8 mg groups, but the rabbits in NC group were not challenged. After 8 weeks of feeding, venous blood of left jugular vein bifurcation and myocardium tissue were harvested respectively for the determination of inflammation and oxidative stress parameters. TNF-α, interleukin-1 (IL-1), adiponectin (ADP), nitric oxide (NO) and total nitric oxide synthase (NOS) levels were determined by enzyme linked immunosorbent assay (ELISA), myeloperoxidase (MPO) activity was determined by colorimetric method, superoxide dismutase (SOD) activity was determined by hydroxylamine method, malondialdehyde (MDA) was determined by thiobarbituric acid colorimetric method, and catalase (CAT) activity was determined by UV spectrophotometry method. In addition, the mRNA expressions of TNF-α and TLR4 were determined by real-time quantitate reverse transcription-polymerase chain reaction (RT-qPCR).

RESULTS

(1) IL-1 and TNF-α in serum and myocardium of model rabbits were significantly increased, ADP was significantly decreased, and the mRNA expressions of TNF-α and TLR4 in myocardium were significantly increased, indicating a significant inflammatory reaction. The inflammatory reaction in pioglitazone intervention groups was significantly reduced, TNF-α and IL-1 levels in serum and myocardium of DM+PGZ 4 mg and 8 mg groups were significantly decreased as compared with those of DM group [serum: TNF-α (ng/L) was 268.33±46.57, 261.34±33.73 vs. 331.40±69.05, myocardium: TNF-α (ng/L) was 144.72±26.90, 139.59±14.59 vs. 177.48±27.40; serum: IL-1 (ng/L) was 24.40±2.56, 23.35±3.13 vs. 30.08±5.44, myocardium: IL-1 (ng/L) was 21.26±2.85, 20.54±2.75 vs. 24.78±3.60, all P < 0.05], and ADP levels were significantly increased [serum (μg/L): 19.64±8.85, 20.54±7.47 vs. 15.45±3.06, myocardium (μg/L): 10.31±2.22, 11.49±3.42 vs. 7.76±1.77, all P < 0.05], and the mRNA expressions of TNF-α and TLR4 in myocardium were significantly decreased (TNF-α mRNA: 0.15±0.05, 0.14±0.06 vs. 0.25±0.09; TLR4 mRNA: 0.57±0.17, 0.40±0.18 vs. 0.75±0.35, all P < 0.05). (2) Oxidative stress in serum and myocardium of model rabbits was significantly increased, SOD, NO, and total NOS levels were significantly decreased while the serum CAT and MDA levels were significantly increased without effect on MPO. Compared with the DM group, SOD and NO levels in serum and myocardium were significantly increased in DM+PGZ 4 mg and 8 mg groups [serum: SOD (U/L) was 571.39±40.85, 609.28±54.47 vs. 535.10±37.08, myocardium: SOD (U/mg) was 55.74±8.12, 53.60±9.87 vs. 42.26±12.34; serum: NO (μmol/L) was 2.95±0.51, 2.99±0.43 vs. 2.03±0.78, myocardium: NO (nmol/mg) was 1.95±0.37, 2.11±0.26 vs. 1.56±0.33, all P < 0.05], the serum MDA levels were significantly decreased (μmol/L: 20.11±2.34, 19.70±2.02 vs. 23.07±3.06, both P < 0.05), while no significant effect on CAT. There was no significant difference in parameter of inflammatory and oxidative stress between the two pioglitazone intervention groups.

CONCLUSIONS

4 mg×kg×d pioglitazone could activate PPARγ-TLR4-TNF-α targeted pathway, thus inhibit inflammatory and oxidative stress factors expression, and down-regulate hyperglycemia induced myocardium inflammatory and oxidative stress level, but the effect did not show a dose dependent manner.

摘要

目的

探讨过氧化物酶体增殖物激活受体γ- Toll样受体4-肿瘤坏死因子-α(PPARγ-TLR4-TNF-α)靶向通路对高血糖诱导的心肌炎症和氧化应激的潜在影响及机制。

方法

将32只健康成年日本白兔随机分为4组,每组8只:正常对照组(NC组)、糖尿病组(DM组)、糖尿病 + 吡格列酮4 mg×kg×d组和8 mg×kg×d组(DM+PGZ 4 mg组和8 mg组)。通过耳静脉注射150 mg/kg的四氧嘧啶复制DM模型。在成功复制DM模型的当天,DM+PGZ 4 mg组和8 mg组的糖尿病兔给予相应剂量的吡格列酮喂养,而NC组的兔不进行处理。喂养8周后,分别采集左颈静脉分叉处的静脉血和心肌组织,测定炎症和氧化应激参数。采用酶联免疫吸附测定法(ELISA)测定肿瘤坏死因子-α(TNF-α)、白细胞介素-1(IL-1)、脂联素(ADP)、一氧化氮(NO)和总一氧化氮合酶(NOS)水平,采用比色法测定髓过氧化物酶(MPO)活性,采用羟胺法测定超氧化物歧化酶(SOD)活性,采用硫代巴比妥酸比色法测定丙二醛(MDA)含量,采用紫外分光光度法测定过氧化氢酶(CAT)活性。此外,采用实时定量逆转录-聚合酶链反应(RT-qPCR)测定TNF-α和TLR4的mRNA表达。

结果

(1)模型兔血清和心肌中的IL-1和TNF-α显著升高,ADP显著降低,心肌中TNF-α和TLR4的mRNA表达显著升高,表明存在明显的炎症反应。吡格列酮干预组的炎症反应显著减轻,DM+PGZ 4 mg组和8 mg组血清和心肌中的TNF-α和IL-1水平与DM组相比显著降低[血清:TNF-α(ng/L)为268.33±46.57、261.34±33.73,DM组为331.40±69.05;心肌:TNF-α(ng/L)为144.72±26.90、139.59±14.59,DM组为177.48±27.40;血清:IL-1(ng/L)为24.40±2.56、23.35±3.13,DM组为30.08±5.44;心肌:IL-1(ng/L)为21.26±2.85、20.54±2.75,DM组为24.78±3.60,均P < 0.05],ADP水平显著升高[血清(μg/L):19.64±8.85、20.54±7.47,DM组为15.45±3.06;心肌(μg/L):10.31±2.22、11.49±3.42,DM组为7.76±1.77,均P < 0.05],心肌中TNF-α和TLR4的mRNA表达显著降低(TNF-α mRNA:0.15±0.05、0.14±0.06,DM组为0.25±0.09;TLR4 mRNA:0.57±0.17、0.40±0.18,DM组为0.75±0.35,均P < 0.05)。(2)模型兔血清和心肌中的氧化应激显著增加,SOD、NO和总NOS水平显著降低,而血清CAT和MDA水平显著升高,对MPO无影响。与DM组相比,DM+PGZ 4 mg组和8 mg组血清和心肌中的SOD和NO水平显著升高[血清:SOD(U/L)为571.39±40.85、609.28±54.47,DM组为535.10±37.08;心肌:SOD(U/mg)为55.74±8.12、53.60±9.87,DM组为42.26±12.34;血清:NO(μmol/L)为2.95±0.51、2.99±0.43,DM组为2.03±0.78;心肌:NO(nmol/mg)为1.95±0.37、2.11±0.26,DM组为1.56±0.33,均P < 0.05],血清MDA水平显著降低(μmol/L:20.11±2.34、19.70±2.02,DM组为23.07±3.06,均P < 0.05),而对CAT无显著影响。两个吡格列酮干预组之间的炎症和氧化应激参数无显著差异。

结论

4 mg×kg×d吡格列酮可激活PPARγ-TLR4-TNF-α靶向通路,从而抑制炎症和氧化应激因子的表达,下调高血糖诱导的心肌炎症和氧化应激水平,但该作用未呈现剂量依赖性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验